Albireo Stock Volatility

ALBO
 Stock
  

USD 23.43  0.35  1.47%   

Albireo Pharma appears to be not too volatile, given 3 months investment horizon. Albireo Pharma secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had 0.15% of return per unit of standard deviation over the last 3 months. Our philosophy in foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By analyzing Albireo Pharma technical indicators you can presently evaluate if the expected return of 0.7% is justified by implied risk. Please makes use of Albireo Pharma's mean deviation of 3.31, and Risk Adjusted Performance of 0.1853 to double-check if our risk estimates are consistent with your expectations.
  
Albireo Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Albireo daily returns, and it is calculated using variance and standard deviation. We also use Albireo's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Albireo Pharma volatility.

30 Days Market Risk

Not too volatile

Chance of Distress

30 Days Economic Sensitivity

Almost mirrors the market
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Albireo Pharma can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Albireo Pharma at lower prices. For example, an investor can purchase Albireo stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Albireo Pharma's stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

Moving together with Albireo Pharma

+0.67ABBVAbbVie IncPairCorr
+0.71AMGNAmgen IncPairCorr

Moving against Albireo Pharma

-0.8CPHIChina Pharma HoldingsPairCorr
-0.72BCELAtreca IncPairCorr
-0.66BIOBio-Rad LaboratoriesPairCorr
-0.65ACADACADIA PharmaceuticalsPairCorr
-0.63BEAMBeam TherapeuticsInc Downward RallyPairCorr

Albireo Pharma Market Sensitivity And Downside Risk

Albireo Pharma's beta coefficient measures the volatility of Albireo stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Albireo stock's returns against your selected market. In other words, Albireo Pharma's beta of 1.11 provides an investor with an approximation of how much risk Albireo Pharma stock can potentially add to one of your existing portfolios.
Albireo Pharma shows above-average downside volatility for the selected time horizon. We advise investors to inspect Albireo Pharma further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Albireo Pharma future alpha. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Albireo Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Albireo Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
3 Months Beta |Analyze Albireo Pharma Demand Trend
Check current 90 days Albireo Pharma correlation with market (NYSE Composite)

Albireo Beta

    
  1.11  
Albireo standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  4.77  
It is essential to understand the difference between upside risk (as represented by Albireo Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Albireo Pharma's daily returns or price. Since the actual investment returns on holding a position in albireo stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Albireo Pharma.

Using Albireo Put Option to Manage Risk

Put options written on Albireo Pharma grant holders of the option the right to sell a specified amount of Albireo Pharma at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Albireo Stock cannot fall below zero, the put buyer does gain as the price drops. So, one way investors can hedge Albireo Pharma's position is by buying a put option against it. The put option used this way is usually referred to as insurance. If an undesired outcome occurs and loss on holding Albireo Pharma will be realized, the loss incurred will be offset by the profits made with the option trade.

Albireo Pharma's PUT expiring on 2022-12-16

   Profit   
Share
       Albireo Pharma Price At Expiration  

Current Albireo Pharma Insurance Chain

DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Put
2022-12-16 PUT at $22.5-0.36080.066212022-12-160.1 - 3.11.6View
View All Albireo Pharma Options

Albireo Pharma Stock Volatility Analysis

Volatility refers to the frequency at which Albireo Pharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Albireo Pharma's price changes. Investors will then calculate the volatility of Albireo Pharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Albireo Pharma's volatility:

Historical Volatility

This type of stock volatility measures Albireo Pharma's fluctuations based on previous trends. It's commonly used to predict Albireo Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Albireo Pharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Albireo Pharma's to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. The Median Price line plots median indexes of Albireo Pharma price series.
.

Albireo Pharma Projected Return Density Against Market

Given the investment horizon of 90 days the stock has the beta coefficient of 1.1052 . This suggests Albireo Pharma market returns are very sensitive to returns on the market. As the market goes up or down, Albireo Pharma is expected to follow.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Albireo Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Albireo Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Albireo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
The company has an alpha of 0.4591, implying that it can generate a 0.46 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
Albireo Pharma's volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how albireo stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives an Albireo Pharma Price Volatility?

Several factors can influence a Stock's stock volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Albireo Pharma Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Albireo Pharma or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Albireo Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Albireo stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Albireo Pharma is 680.92. The daily returns are distributed with a variance of 22.74 and standard deviation of 4.77. The mean deviation of Albireo Pharma is currently at 3.31. For similar time horizon, the selected benchmark (NYSE Composite) has volatility of 1.48
α
Alpha over NYSE Composite
0.46
β
Beta against NYSE Composite1.11
σ
Overall volatility
4.77
Ir
Information ratio 0.1

Albireo Pharma Stock Return Volatility

Albireo Pharma historical daily return volatility represents how much of Albireo Pharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 4.7687% risk (volatility on return distribution) over the 90 days horizon. By contrast, NYSE Composite accepts 12.5075% volatility on return distribution over the 90 days horizon.
 Performance (%) 
       Timeline  

About Albireo Pharma Volatility

Volatility is a rate at which the price of Albireo Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Albireo Pharma may increase or decrease. In other words, similar to Albireo's beta indicator, it measures the risk of Albireo Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Albireo Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Last ReportedProjected for 2022
Market Capitalization449 M357.5 M

Albireo Pharma Investment Opportunity

NYSE Composite has a standard deviation of returns of 12.51 and is 2.62 times more volatile than Albireo Pharma. 41  of all equities and portfolios are less risky than Albireo Pharma. Compared to the overall equity markets, volatility of historical daily returns of Albireo Pharma is lower than 41 () of all global equities and portfolios over the last 90 days. Use Albireo Pharma to protect your portfolios against small market fluctuations. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Albireo Pharma to be traded at $22.73 in 90 days.

Weak diversification

The correlation between Albireo Pharma and NYA is 0.34 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Albireo Pharma and NYA in the same portfolio, assuming nothing else is changed.

Albireo Pharma Additional Risk Indicators

The analysis of Albireo Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Albireo Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Albireo Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Albireo Pharma Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Albireo Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Albireo Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Albireo Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Albireo Pharma.
Please continue to Trending Equities. Note that the Albireo Pharma information on this page should be used as a complementary analysis to other Albireo Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Albireo Stock analysis

When running Albireo Pharma price analysis, check to measure Albireo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Albireo Pharma is operating at the current time. Most of Albireo Pharma's value examination focuses on studying past and present price action to predict the probability of Albireo Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Albireo Pharma's price. Additionally, you may evaluate how the addition of Albireo Pharma to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Albireo Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Albireo Pharma. If investors know Albireo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Albireo Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
492.3 M
Quarterly Revenue Growth YOY
1.68
Return On Assets
(0.25) 
Return On Equity
(0.93) 
The market value of Albireo Pharma is measured differently than its book value, which is the value of Albireo that is recorded on the company's balance sheet. Investors also form their own opinion of Albireo Pharma's value that differs from its market value or its book value, called intrinsic value, which is Albireo Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Albireo Pharma's market value can be influenced by many factors that don't directly affect Albireo Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Albireo Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Albireo Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Albireo Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.